Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis
Mark C. Genovese, Josef S Smolen, Tsutomu Takeuchi, Gerd R Burmester, Dennis Brinker, Terence Rooney, Jinglin Zhong, Daojun Mo, Chadi Saifan, Anabela Cardoso, Maher Issa, Wen‐Shuo Wu, Kevin Winthrop
Topics & Concepts
MedicineRheumatoid arthritisSafety profileInternal medicineAdverse effectRheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchSpondyloarthritis Studies and Treatments